Beatson West of Scotland Cancer Centre

Multimodal artificial intelligence (MMAI) model to identify benefit from 2nd-generation androgen receptor pathway inhibitors (ARPI) in high-risk non-metastatic prostate cancer patients from STAMPEDE.

Charles Thomas Parker, Vinnie YT Liu, Larissa Mendes et al.

2025 · 2 Zit.

Protocol for the PROSECCA study: a new approach for predicting radiotherapy outcome using artificial intelligence and electronic population-based healthcare data

William H. Nailon, David J. Noble, Ewen M Harrison et al.

2026 · 0 Zit.